Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mello-Tonin appears to be a **dietary supplement product** marketed under the brand name Mello-Tonin and associated with Basic Reset. Publicly available information identifies it as one of the dietary supplements recalled in connection with FDA and DOJ actions against Basic Reset and Biogenyx for distribution of misbranded and adulterated products. The exact active ingredient composition, dosage strength, formulation details, developer, manufacturer specifications, intended indication, and mechanism of action are not clearly established from the available evidence I could verify. Based on the name, it may have been intended as a melatonin-containing sleep-related supplement, but that specific composition could not be confirmed with sufficient certainty, so its pharmacology should be treated as unverified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mello-Tonin.